Greenwich LifeSciences (GLSI) Net Equity Issued and Repurchased (2020 - 2024)
Greenwich LifeSciences (GLSI) posted Net Equity Issued and Repurchased of $1.2 million for Q3 2024, up 342.91% on a QoQ basis from $266742.0 in Q2 2024.
Greenwich LifeSciences (GLSI) Net Equity Issued and Repurchased (2020 - 2024) Analysis & Trends
Greenwich LifeSciences' Net Equity Issued and Repurchased history runs 3 years deep, the most recent figure standing at $1.2 million for Q3 2024.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $1.2 million in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $2.3 million (changed N/A YoY) and the FY2021 annual result came in at $3.1 million, down 89.69% from the prior year.
- Net Equity Issued and Repurchased was $1.2 million for Q3 2024 at Greenwich LifeSciences, up from $266742.0 in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $24.0 million in Q4 2020 and bottomed at $266742.0 in Q2 2024.
- A 3-year average of $4.8 million and a median of $872010.0 in 2021 frame the typical range for Net Equity Issued and Repurchased.
- Peak annual rise in Net Equity Issued and Repurchased reached 97.65% in 2021, while the deepest fall reached 97.65% in 2021.
- Greenwich LifeSciences' Net Equity Issued and Repurchased stood at $24.0 million in 2020, then slumped by 97.65% to $562596.0 in 2021, then jumped by 110.0% to $1.2 million in 2024.
- Business Quant data shows GLSI's Net Equity Issued and Repurchased at $1.2 million in Q3 2024, $266742.0 in Q2 2024, and $299116.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 141.90 Mn |
| 10 | Greenwich LifeSciences | 178.53 Mn | 178.53 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 1.18 Mn |
| Sep 30, 2024 | 1.18 Mn |
| Jun 30, 2024 | 266,742.00 |
| Jun 30, 2024 | 266,742.00 |
| Mar 31, 2024 | 299,116.00 |
| Mar 31, 2024 | 299,116.00 |
| Dec 31, 2021 | 562,596.00 |
| Dec 31, 2021 | 562,596.00 |
| Mar 31, 2021 | 2.55 Mn |
| Mar 31, 2021 | 2.55 Mn |
| Dec 31, 2020 | 23.96 Mn |
| Dec 31, 2020 | 23.96 Mn |